IRC Clinics

Towson, Maryland 21204

0 studies enrolling now · 9 studies all time

What they study most

Adverse Drug Events, Adverse Drug Reactions, Arthritis, Rheumatoid, Cardiovascular Disease, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency, Cytochrome P450 CYP2D6 Enzyme Deficiency, Cytochrome P450 CYP3A Enzyme Deficiency, Cytochrome P450 Enzyme Deficiency, Drug Interaction Potentiation, Drug Metabolism, Poor, CYP2C19-RELATED, Drug Metabolism, Poor, CYP2D6-RELATED

Studies at this site

• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects — Completed
• YouScript IMPACT Registry — Completed
• Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study — Completed
• Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine — Completed
• Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism — Completed
• Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia — Completed